Cite
Development and evaluation of oxaliplatin and irinotecan co-loaded liposomes for enhanced colorectal cancer therapy.
MLA
Zhang, Bo, et al. “Development and Evaluation of Oxaliplatin and Irinotecan Co-Loaded Liposomes for Enhanced Colorectal Cancer Therapy.” Journal of Controlled Release, vol. 238, Sept. 2016, pp. 10–21. EBSCOhost, https://doi.org/10.1016/j.jconrel.2016.07.022.
APA
Zhang, B., Wang, T., Yang, S., Xiao, Y., Song, Y., Zhang, N., & Garg, S. (2016). Development and evaluation of oxaliplatin and irinotecan co-loaded liposomes for enhanced colorectal cancer therapy. Journal of Controlled Release, 238, 10–21. https://doi.org/10.1016/j.jconrel.2016.07.022
Chicago
Zhang, Bo, Tianqi Wang, Shaomei Yang, Yanan Xiao, Yunmei Song, Na Zhang, and Sanjay Garg. 2016. “Development and Evaluation of Oxaliplatin and Irinotecan Co-Loaded Liposomes for Enhanced Colorectal Cancer Therapy.” Journal of Controlled Release 238 (September): 10–21. doi:10.1016/j.jconrel.2016.07.022.